跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bulk Quadrivalent Influenza Vaccine (split virion, inactivated) Thiomersal containing - TGA Drug Approval Details
Approvals
/
TGA
/
Bulk Quadrivalent Influenza Vaccine (split virion, inactivated) Thiomersal containing
Approved
STANDARD
Bulk Quadrivalent Influenza Vaccine (split virion, inactivated) Thiomersal containing
Seqirus Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
273597ca9a885402
Company
Seqirus Pty Ltd
Type
Standard
Approval Details
Approval Id
273597ca9a885402
Product Name
Bulk Quadrivalent Influenza Vaccine (split virion, inactivated) Thiomersal containing
Artg Id
287846
Artg Name
Bulk Quadrivalent Influenza Vaccine (split virion, inactivated) Thiomersal containing
Sponsor
Seqirus Pty Ltd
Company Detail Path
/organization/seqirus-pty-ltd
Artg Date
2017-04-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
273597ca9a885402
Type
Standard
Back to TGA Approvals
